In summary, our data demonstrated for the first time that As-IV reversed the endothelial dysfunction induced by high glucose by inhibiting the activation of P2X7R/P38 MAPK signaling pathway, thereby inhibiting the upregulation of inflammation and oxidative stress, which ultimately improved vascular endothelium-dependent relaxation (Figure 9). This evidence concerns the gene MAPK14 and endothelial dysfunction.